Cyclosporine trough levels comparison with AUC during conversion to microemulsion formulation (''Neoral'').

被引：0
|
作者：
Heifets, M
Sellers, P
Sallas, W
Browne, B
Samuels, LA
Cooney, G
机构：
[1] TEMPLE UNIV HOSP & MED SCH, DEPT MED, PHILADELPHIA, PA 19140 USA
[2] TEMPLE UNIV HOSP & MED SCH, DEPT SURG, PHILADELPHIA, PA 19140 USA
[3] TEMPLE UNIV HOSP & MED SCH, DEPT PHARM, PHILADELPHIA, PA 19140 USA
[4] SANDOZ RES INST, E HANOVER, NJ USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3322 / A3322
页数：1
相关论文
共 50 条
  • [1] Improved correlation between trough cyclosporine levels and AUC's for new oral microemulsion formulation
    Cooney, GF
    Sellers, P
    Browne, B
    Mancano, M
    Sallas, WM
    Heifets, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI104 - PI104
  • [2] Cyclosporine microemulsion formulation (Neoral) in transplantation: Pharmacokinetic/pharmacodynamic relationships
    Mueller, EA
    Niese, D
    Mellein, B
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1694 - 1696
  • [3] Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients
    Dibo-Cohen, JM
    Conort, O
    Conti, F
    Bernard, D
    Hazebroucq, G
    Calmus, Y
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1857 - 1857
  • [4] CONVERSION TO CYCLOSPORINE MICROEMULSION (NEORAL(R)) AFTER RENAL-TRANSPLANTATION
    WATSCHINGER, B
    ALTAIEE, B
    HORL, WH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1121 - 1121
  • [5] Pharmacokinetics of oral cyclosporine microemulsion formulation (Neoral) in children awaiting renal transplantation
    Gusmano, R
    Basile, GC
    Perfumo, F
    Ginevri, F
    Verrina, E
    Famularo, L
    Corbetta, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1985 - 1987
  • [6] THE NEORAL FORMULATION - IMPROVED CORRELATION BETWEEN CYCLOSPORINE TROUGH LEVELS AND EXPOSURE IN STABLE RENAL-TRANSPLANT RECIPIENTS
    KAHAN, BD
    DUNN, J
    FITTS, C
    VANBUREN, D
    WOMBOLT, D
    POLLAK, R
    CARSON, R
    ALEXANDER, JW
    CHANG, C
    CHOC, M
    WONG, R
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2940 - 2943
  • [7] Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient
    Maeda, Y
    Kuzuya, T
    Ota, S
    Yamada, K
    Kobayashi, T
    Hayashi, S
    Yokoyama, I
    Nakao, A
    Nabeshima, T
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2784 - 2787
  • [8] Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers
    Kees, F
    Bucher, M
    Schweda, F
    Gschaidmeier, H
    Burhenne, J
    Mikus, G
    Faerber, L
    THERAPEUTIC DRUG MONITORING, 2006, 28 (03) : 312 - 320
  • [9] Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine
    Bokenkamp, A
    Offner, G
    Hoyer, PF
    Wonigeit, K
    Brodehl, J
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2273 - 2275
  • [10] A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral)
    Foradori, A
    Pinto, VM
    Elberg, A
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1666 - 1667
12345